Rothblatt Martine A's Form 4 filing
United Therapeutics Corp (UTHR) · filed Aug 21, 2026
- Accession no.
- 0001106578-26-000125
- Filed
- Aug 21, 2026, 4:44 PM ET
- Trade date
- Aug 20, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 9 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.95M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rothblatt Martine ACIK 0001106578 | Director, Officer (Chairperson & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | Common Stock | MOption exerciseAcquired | +9,500 | $135.42 | +$1,286,490 | 333,943 | Indirect | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −976 | $518.45F3 | −$506,005.54 | 332,967 | Indirect | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −1,504 | $519.51F4 | −$781,344.09 | 331,463 | Indirect | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −2,357 | $520.46F5 | −$1,226,712.67 | 329,106 | Indirect | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −2,470 | $521.39F6 | −$1,287,842.93 | 326,636 | Indirect | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −960 | $522.37F7 | −$501,476.64 | 325,676 | Indirect | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −800 | $523.26F8 | −$418,606.56 | 324,876 | Indirect | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −240 | $525.10F9 | −$126,023.11 | 324,636 | Indirect | |
| Aug 20, 2026 | Common Stock | SSaleDisposed | −193 | $526.97F10 | −$101,705.19 | 324,443 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 | Common Stock | MOption exerciseDisposed | −9,500 | $0.00 | $0 | 94,410 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This transaction was executed in multiple trades at prices ranging from $517.88 to $518.85. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $518.92 to $519.845. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $519.95 to $520.94. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $520.96 to $521.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F7
This transaction was executed in multiple trades at prices ranging from $521.96 to $522.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $522.96 to $523.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $524.47 to $525.435. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F10
This transaction was executed in multiple trades at prices ranging from $526.80 to $527.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.